First-in-Human Trial for Tebentafusp In Advanced Melanoma Shows Promising Safety Profile
The first-in-human trial for tebentafusp findings are in, and they show promise for managing a patients side effects to it.
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical Cannabis
Improvements in Health Systems Model Reduces Disparities in Leukemia Survival in Low-Income Countries
Telephone and Web-Based Program Elicits Clinically Meaningful Results in Breast Cancer Survivors
Luspatercept Elicits High Transfusion Independence Rates in Lower-Risk MDS
2 Clarke Drive Cranbury, NJ 08512